José Eduardo Tanus‐santos
#161,193
Most Influential Person Now
José Eduardo Tanus‐santos's AcademicInfluence.com Rankings
José Eduardo Tanus‐santosengineering Degrees
Engineering
#6947
World Rank
#8304
Historical Rank
Biomedical Engineering
#657
World Rank
#669
Historical Rank
Applied Physics
#2322
World Rank
#2362
Historical Rank
Download Badge
Engineering
Why Is José Eduardo Tanus‐santos Influential?
(Suggest an Edit or Addition)José Eduardo Tanus‐santos's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Cell-free hemoglobin limits nitric oxide bioavailability in sickle-cell disease (2002) (684)
- A Critical Review of Biomarkers Used for Monitoring Human Exposure to Lead: Advantages, Limitations, and Future Needs (2005) (621)
- Cell-free hemoglobin limits nitric oxide bioavailability in sickle-cell disease. (2002) (539)
- Effects of ethnicity on the distribution of clinically relevant endothelial nitric oxide variants. (2001) (303)
- Metalloproteinase inhibition ameliorates hypertension and prevents vascular dysfunction and remodeling in renovascular hypertensive rats. (2008) (167)
- Nitric Oxide Formation Is Inversely Related to Serum Levels of Antiangiogenic Factors Soluble Fms-Like Tyrosine Kinase-1 and Soluble Endogline in Preeclampsia (2008) (164)
- Biological activity of nitric oxide in the plasmatic compartment. (2004) (151)
- Consistent interethnic differences in the distribution of clinically relevant endothelial nitric oxide synthase genetic polymorphisms. (2005) (149)
- Circulating interleukin-6 and high-sensitivity C-reactive protein decrease after periodontal therapy in otherwise healthy subjects. (2009) (147)
- Antioxidant treatment reduces matrix metalloproteinase-2-induced vascular changes in renovascular hypertension. (2009) (141)
- Gingival crevicular fluid levels of MMP-8, MMP-9, TIMP-2, and MPO decrease after periodontal therapy. (2010) (140)
- Implications of cytochrome P450 interactions when prescribing medication for hypertension. (2002) (139)
- Methodological issues affecting the determination of plasma matrix metalloproteinase (MMP)-2 and MMP-9 activities. (2005) (125)
- Sodium nitrite downregulates vascular NADPH oxidase and exerts antihypertensive effects in hypertension. (2011) (125)
- Rapid separation of serum does not avoid artificially higher matrix metalloproteinase (MMP)-9 levels in serum versus plasma. (2007) (124)
- Effect of anticoagulants on the determination of plasma matrix metalloproteinase (MMP)-2 and MMP-9 activities. (2005) (124)
- Effects of endothelial nitric oxide synthase gene polymorphisms on platelet function, nitric oxide release, and interactions with estradiol. (2002) (114)
- Endothelial nitric oxide synthase gene haplotypes associated with circulating concentrations of nitric oxide products in healthy men (2005) (114)
- Modulation of nitric oxide formation by endothelial nitric oxide synthase gene haplotypes. (2007) (113)
- Susceptible and protective eNOS haplotypes in hypertensive black and white subjects. (2006) (111)
- Comparative assessment of matrix metalloproteinase (MMP)-2 and MMP-9, and their inhibitors, tissue inhibitors of metalloproteinase (TIMP)-1 and TIMP-2 in preeclampsia and gestational hypertension. (2008) (98)
- Imbalance between matrix metalloproteinases and tissue inhibitor of metalloproteinases in hypertensive vascular remodeling. (2010) (95)
- Circulating matrix metalloproteinase-8 (MMP-8) and MMP-9 are increased in chronic periodontal disease and decrease after non-surgical periodontal therapy. (2009) (92)
- Hemolysis during cardiac surgery is associated with increased intravascular nitric oxide consumption and perioperative kidney and intestinal tissue damage (2014) (90)
- Endothelial nitric oxide synthase: From biochemistry and gene structure to clinical implications of NOS3 polymorphisms. (2016) (90)
- Increased circulating levels of matrix metalloproteinase (MMP)-8, MMP-9, and pro-inflammatory markers in patients with metabolic syndrome. (2009) (86)
- eNOS haplotypes associated with gestational hypertension or preeclampsia. (2008) (86)
- Endothelial nitric oxide synthase haplotypes affect the susceptibility to hypertension in patients with type 2 diabetes mellitus. (2006) (86)
- Influence of eNOS haplotypes on the plasma nitric oxide products concentrations in hypertensive and type 2 diabetes mellitus patients. (2007) (83)
- Lercanidipine Reduces Matrix Metalloproteinase-9 Activity in Patients With Hypertension (2006) (81)
- Effect of exercise training on plasma levels and functional properties of high-density lipoprotein cholesterol in the metabolic syndrome. (2011) (81)
- Low-dose intravenous nitrite improves hemodynamics in a canine model of acute pulmonary thromboembolism. (2006) (80)
- eNOS gene T-786C polymorphism modulates atorvastatin-induced increase in blood nitrite. (2006) (80)
- The Effect of Sildenafil on Pulmonary Embolism-Induced Oxidative Stress and Pulmonary Hypertension (2005) (77)
- Gastric S-nitrosothiol formation drives the antihypertensive effects of oral sodium nitrite and nitrate in a rat model of renovascular hypertension. (2015) (76)
- Matrix metalloproteinases: targets for doxycycline to prevent the vascular alterations of hypertension. (2011) (75)
- Relationship between systemic nitric oxide metabolites and cyclic GMP in healthy male volunteers (2006) (73)
- Effects of statins on matrix metalloproteinases and their endogenous inhibitors in human endothelial cells (2011) (72)
- Blood transfusions increase circulating plasma free hemoglobin levels and plasma nitric oxide consumption: a prospective observational pilot study (2012) (72)
- Anti-inflammatory effects of atorvastatin: modulation by the T-786C polymorphism in the endothelial nitric oxide synthase gene. (2007) (72)
- Enhanced concentrations of relevant markers of nitric oxide formation after exercise training in patients with metabolic syndrome. (2008) (71)
- Increase in gastric pH reduces hypotensive effect of oral sodium nitrite in rats. (2012) (71)
- Vascular endothelial growth factor genotypes and haplotypes are associated with pre-eclampsia but not with gestational hypertension. (2008) (70)
- Chemical composition, antioxidant and anticholinesterase activity of Melissa officinalis (2014) (70)
- Protective effects of atorvastatin in rat models of acute pulmonary embolism: Involvement of matrix metalloproteinase‐9* (2007) (69)
- Endothelial nitric oxide synthase haplotypes are related to blood pressure elevation, but not to resistance to antihypertensive drug therapy (2006) (67)
- Circulating matrix metalloproteinases and their inhibitors in hypertension. (2012) (66)
- Inducible nitric oxide synthase as a possible target in hypertension. (2014) (65)
- eNOS haplotypes affect the responsiveness to antihypertensive therapy in preeclampsia but not in gestational hypertension (2010) (64)
- Atorvastatin enhances sildenafil-induced vasodilation through nitric oxide-mediated mechanisms. (2004) (63)
- Nonselective endothelin-receptor antagonism attenuates hemodynamic changes after massive pulmonary air embolism in dogs. (2000) (62)
- Matrix metalloproteinase inhibition improves cardiac dysfunction and remodeling in 2-kidney, 1-clip hypertension. (2010) (61)
- Uncontrolled hypertension, uncompensated type II diabetes, and smoking have different patterns of vascular dysfunction. (2004) (59)
- Doxycycline ameliorates 2K-1C hypertension-induced vascular dysfunction in rats by attenuating oxidative stress and improving nitric oxide bioavailability. (2012) (58)
- eNOS genotype is without effect on circulating nitrite/nitrate level in healthy male population. (2005) (58)
- Nebivolol attenuates prooxidant and profibrotic mechanisms involving TGF-β and MMPs, and decreases vascular remodeling in renovascular hypertension. (2013) (58)
- Matrix metalloproteinases as drug targets in preeclampsia. (2013) (58)
- A polymorphism in the delta-aminolevulinic acid dehydratase gene modifies plasma/whole blood lead ratio (2006) (57)
- Time course involvement of matrix metalloproteinases in the vascular alterations of renovascular hypertension. (2012) (57)
- Evaluation of the use of salivary lead levels as a surrogate of blood lead or plasma lead levels in lead exposed subjects (2006) (56)
- l-Arginine attenuates acute pulmonary embolism-induced oxidative stress and pulmonary hypertension. (2005) (56)
- Sildenafil selectively inhibits acute pulmonary embolism-induced pulmonary hypertension. (2005) (56)
- Assessment of matrix metalloproteinase (MMP)-2, MMP-8, MMP-9, and their inhibitors, the tissue inhibitors of metalloproteinase (TIMP)-1 and TIMP-2 in obese children and adolescents. (2009) (55)
- Association between matrix metalloproteinase (MMP)-2 polymorphisms and MMP-2 levels in hypertensive disorders of pregnancy. (2012) (54)
- Inhibition of matrix metalloproteinases (MMPs) as a potential strategy to ameliorate hypertension-induced cardiovascular alterations. (2013) (54)
- Association of polymorphisms of endothelial nitric oxide synthase (eNOS) gene with the risk of primary open angle glaucoma in a Brazilian population. (2012) (53)
- Effects of eNOS polymorphisms on nitric oxide formation in healthy pregnancy and in pre-eclampsia. (2010) (52)
- Hemodynamic effects of combined sildenafil and L-arginine during acute pulmonary embolism-induced pulmonary hypertension. (2005) (51)
- Temporal changes in cardiac matrix metalloproteinase activity, oxidative stress, and TGF-β in renovascular hypertension-induced cardiac hypertrophy. (2013) (51)
- Transdermal nicotine mimics the smoking‐induced endothelial dysfunction * (2000) (51)
- Evaluation of plasmatic MMP-8, MMP-9, TIMP-1 and MPO levels in obese and lean women. (2012) (50)
- Consistent alterations of circulating matrix metalloproteinases levels in untreated hypertensives and in spontaneously hypertensive rats: a relevant pharmacological target. (2011) (49)
- Salivary MMPs, TIMPs, and MPO levels in periodontal disease patients and controls. (2013) (49)
- Tempol inhibits TGF-β and MMPs upregulation and prevents cardiac hypertensive changes. (2013) (48)
- Clinical and pharmacogenetic impact of endothelial nitric oxide synthase polymorphisms on cardiovascular diseases. (2017) (48)
- Functional polymorphisms in the promoter of the matrix metalloproteinase-9 (MMP-9) gene are not linked with significant plasma MMP-9 variations in healthy subjects (2008) (47)
- Hemodynamic Benefits of Matrix Metalloproteinase-9 Inhibition by Doxycycline During Experimental Acute Pulmonary Embolism (2005) (46)
- Sildenafil reduces cardiovascular remodeling associated with hypertensive cardiomyopathy in NOS inhibitor-treated rats. (2006) (46)
- Haplotypes of vitamin D receptor modulate the circulating levels of lead in exposed subjects (2007) (46)
- Lercanidipine reduces matrix metalloproteinase-2 activity and reverses vascular dysfunction in renovascular hypertensive rats. (2008) (45)
- Doxycycline Dose‐dependently Inhibits MMP‐2‐Mediated Vascular Changes in 2K1C Hypertension (2011) (45)
- A role for matrix metalloproteinase-9 in the hemodynamic changes following acute pulmonary embolism. (2007) (45)
- Increased circulating cell-free hemoglobin levels reduce nitric oxide bioavailability in preeclampsia. (2010) (45)
- Hemodynamic effects of sildenafil interaction with a nitric oxide donor compound in a dog model of acute pulmonary embolism. (2006) (45)
- Matrix metalloproteinase (MMP)-9 genotypes and haplotypes in preeclampsia and gestational hypertension. (2010) (44)
- Clinical evidence for lead-induced inhibition of nitric oxide formation (2006) (44)
- Genetic polymorphism of matrix metalloproteinase (MMP)-9 does not affect plasma MMP-9 activity in healthy subjects. (2006) (44)
- Lead in saliva from lead-exposed and unexposed children. (2009) (44)
- L-arginine attenuates acute pulmonary embolism-induced increases in lung matrix metalloproteinase-2 and matrix metalloproteinase-9. (2005) (43)
- Consistent antioxidant and antihypertensive effects of oral sodium nitrite in DOCA-salt hypertension (2015) (42)
- Endothelial nitric oxide synthase gene haplotypes affect nitrite levels in black subjects (2011) (42)
- β1-Adrenergic blockers exert antioxidant effects, reduce matrix metalloproteinase activity, and improve renovascular hypertension-induced cardiac hypertrophy. (2014) (41)
- eNOS and BDKRB2 genotypes affect the antihypertensive responses to enalapril (2013) (41)
- Quercetin restores plasma nitrite and nitroso species levels in renovascular hypertension (2010) (40)
- Small-dose inhaled nitric oxide attenuates hemodynamic changes after pulmonary air embolism in dogs. (1999) (40)
- Quercetin decreases the activity of matrix metalloproteinase-2 and ameliorates vascular remodeling in renovascular hypertension. (2018) (40)
- Interethnic differences in ADMA concentrations and negative association with nitric oxide formation in preeclampsia. (2010) (39)
- Positive correlations between circulating adiponectin and MMP2 in preeclampsia pregnant. (2015) (39)
- Antihypertensive and antioxidant effects of a single daily dose of sodium nitrite in a model of renovascular hypertension (2012) (39)
- TEMPOL enhances the antihypertensive effects of sodium nitrite by mechanisms facilitating nitrite-derived gastric nitric oxide formation. (2013) (38)
- Endothelial nitric oxide synthase haplotypes associated with aura in patients with migraine. (2011) (38)
- Matrix metalloproteinase-9 genetic variations affect MMP-9 levels in obese children (2012) (38)
- Inverse relationship between markers of nitric oxide formation and plasma matrix metalloproteinase-9 levels in healthy volunteers. (2008) (37)
- Pharmacokinetics and QT interval pharmacodynamics of oral haloperidol in poor and extensive metabolizers of CYP2D6 (2003) (37)
- Isoflavone genistein inhibits the angiotensin-converting enzyme and alters the vascular responses to angiotensin I and bradykinin. (2009) (37)
- A pharmacogenetics-based approach to reduce cardiovascular mortality with the prophylactic use of statins. (2010) (37)
- Antioxidant effect of doxycycline decreases MMP activity and blood pressure in SHR (2013) (37)
- Fluoride increases lead concentrations in whole blood and in calcified tissues from lead-exposed rats. (2010) (37)
- Inhaled nitric oxide improves hemodynamics during a venous air infusion (VAI) in dogs (1999) (36)
- Common matrix metalloproteinase 2 gene haplotypes may modulate left ventricular remodelling in hypertensive patients (2012) (36)
- Endothelial nitric oxide synthase polymorphisms and haplotypes in Amerindians. (2009) (36)
- Whole blood, serum, and saliva lead concentrations in 6- to 8-year-old children. (2010) (36)
- Imbalanced circulating matrix metalloproteinases in polycystic ovary syndrome (2011) (35)
- Endothelin ET(A) receptor antagonism attenuates the pressor effects of nicotine in rats. (2000) (35)
- Vascular xanthine oxidoreductase contributes to the antihypertensive effects of sodium nitrite in l-NAME hypertension (2014) (35)
- Atorvastatin and sildenafil lower blood pressure and improve endothelial dysfunction, but only atorvastatin increases vascular stores of nitric oxide in hypertension☆ (2013) (34)
- Endothelial nitric oxide synthase genotype and haplotype are not associated with diabetic retinopathy in diabetes type 2 patients. (2006) (34)
- Matrix metalloproteinase (MMP)-2 gene polymorphisms affect circulating MMP-2 levels in patients with migraine with aura. (2013) (34)
- Different circulating metalloproteinases profiles in women with migraine with and without aura. (2009) (34)
- Epistasis among eNOS, MMP-9 and VEGF maternal genotypes in hypertensive disorders of pregnancy (2012) (34)
- eNOS haplotype associated with hypertension in obese children and adolescents (2011) (34)
- Antihypertensive effects of inducible nitric oxide synthase inhibition in experimental pre-eclampsia (2013) (34)
- Oral nitrite circumvents antiseptic mouthwash-induced disruption of enterosalivary circuit of nitrate and promotes nitrosation and blood pressure lowering effect. (2016) (34)
- Interaction among nitric oxide (NO)-related genes in migraine susceptibility (2012) (33)
- Contrasting effects of aliskiren versus losartan on hypertensive vascular remodeling. (2013) (33)
- Matrix metalloproteinase 9 gene haplotypes affect left ventricular hypertrophy in hypertensive patients. (2010) (33)
- Inducible nitric oxide synthase haplotype associated with migraine and aura (2012) (33)
- Dose-dependent beneficial hemodynamic effects of BAY 41-2272 in a canine model of acute pulmonary thromboembolism. (2008) (33)
- eNOS genotype-dependent correlation between whole blood lead and plasma nitric oxide products concentrations. (2006) (33)
- Positive correlations between serum and plasma matrix metalloproteinase (MMP)-2 or MMP-9 levels in disease conditions (2009) (32)
- Differences in both matrix metalloproteinase 9 concentration and zymographic profile between plasma and serum with clot activators are due to the presence of amorphous silica or silicate salts in blood collection devices. (2008) (32)
- Vascular endothelial growth factor genetic polymorphisms and haplotypes in women with migraine. (2010) (32)
- Omeprazole impairs vascular redox biology and causes xanthine oxidoreductase-mediated endothelial dysfunction (2016) (32)
- Endothelial nitric oxide synthase genotypes and haplotypes modify the responses to sildenafil in patients with erectile dysfunction (2011) (32)
- Interethnic differences in the distribution of matrix metalloproteinases genetic polymorphisms are consistent with interethnic differences in disease prevalence. (2010) (32)
- The Hemodynamic Effects of Endothelin Receptor Antagonism During a Venous Air Infusion in Dogs (2000) (32)
- Increased Circulating MMP-2 Levels in Infertile Patients With Moderate and Severe Pelvic Endometriosis (2013) (32)
- Circulating cell-free DNA levels in plasma increase with severity in experimental acute pulmonary thromboembolism. (2009) (31)
- Tissue inhibitor of matrix metalloproteinase-1 polymorphism, plasma TIMP-1 levels, and antihypertensive therapy responsiveness in hypertensive disorders of pregnancy (2014) (30)
- Hemodynamic effects of inducible nitric oxide synthase inhibition combined with sildenafil during acute pulmonary embolism. (2010) (30)
- Inducible nitric oxide synthase haplotype associated with hypertension and responsiveness to antihypertensive drug therapy. (2013) (30)
- Metalloproteinase inhibition protects against cardiomyocyte injury during experimental acute pulmonary thromboembolism* (2011) (30)
- Matrix metalloproteinase-9 genotypes and haplotypes are associated with multiple sclerosis and with the degree of disability of the disease (2009) (30)
- Lead contents in the surface enamel of primary and permanent teeth, whole blood, serum, and saliva of 6- to 8-year-old children. (2011) (30)
- The relationship between blood and serum lead levels in peripartum women and their respective umbilical cords. (2010) (30)
- Plasma from pre‐eclamptic patients induces the expression of the anti‐angiogenic miR‐195‐5p in endothelial cells (2016) (30)
- Sildenafil improves the beneficial haemodynamic effects of intravenous nitrite infusion during acute pulmonary embolism. (2008) (30)
- Cardiovascular effects of transdermal nicotine in mildly hypertensive smokers. (2001) (30)
- Atorvastatin and sildenafil decrease vascular TGF-β levels and MMP-2 activity and ameliorate arterial remodeling in a model of renovascular hypertension (2015) (30)
- The potential of stimulating nitric oxide formation in the treatment of hypertension (2017) (29)
- Vascular Damage in Resistant Hypertension: TNF-Alpha Inhibition Effects on Endothelial Cells (2015) (29)
- Lercanidipine decreases vascular matrix metalloproteinase-2 activity and protects against vascular dysfunction in diabetic rats. (2008) (29)
- A genetic polymorphism of matrix metalloproteinase 9 (MMP-9) affects the changes in circulating MMP-9 levels induced by highly active antiretroviral therapy in HIV patients (2009) (29)
- Environmental exposure to methylmercury is associated with a decrease in nitric oxide production. (2009) (28)
- Comparative study on antioxidant effects and vascular matrix metalloproteinase-2 downregulation by dihydropyridines in renovascular hypertension (2010) (27)
- An interethnic comparison of the distribution of vitamin D receptor genotypes and haplotypes. (2007) (27)
- Interethnic differences in the distribution of clinically relevant vascular endothelial growth factor genetic polymorphisms. (2009) (27)
- Nitrite or sildenafil, but not BAY 41-2272, blunt acute pulmonary embolism-induced increases in circulating matrix metalloproteinase-9 and oxidative stress. (2009) (26)
- Evidence for the involvement of matrix metalloproteinases in the cardiovascular effects produced by nicotine. (2010) (26)
- eNOS T-786C polymorphism affects atorvastatin-induced changes in erythrocyte membrane fluidity (2009) (26)
- Effects of Angiotensin‐Converting Enzyme Inhibition on Leptin and Adiponectin Levels in Essential Hypertension (2014) (26)
- Polymorphisms in VEGFA gene affect the antihypertensive responses to enalapril (2015) (26)
- Contrasting effects of age on the plasma/whole blood lead ratio in men and women with a history of lead exposure. (2006) (26)
- Matrix metalloproteinase-9 activity in plasma correlates with plasma and whole blood lead concentrations. (2006) (26)
- The Nuclear Factor kappaB Inhibitor Pyrrolidine Dithiocarbamate Prevents Cardiac Remodelling and Matrix Metalloproteinase‐2 Up‐Regulation in Renovascular Hypertension (2015) (26)
- NADPH Oxidase Plays a Role on Ethanol-Induced Hypertension and Reactive Oxygen Species Generation in the Vasculature. (2016) (25)
- Effect of metabolic syndrome risk factors and MMP-2 genetic variations on circulating MMP-2 levels in childhood obesity (2013) (25)
- Evidence of early involvement of matrix metalloproteinase-2 in lead-induced hypertension (2009) (25)
- Mechanisms impairing blood pressure responses to nitrite and nitrate. (2019) (25)
- Hydrogen peroxide modulates phenylephrine-induced contractile response in renal hypertensive rat aorta. (2013) (25)
- Matrix Metalloproteinases and Arterial Hypertension: Role of Oxidative Stress and Nitric Oxide in Vascular Functional and Structural Alterations (2021) (25)
- Relationship between adiponectin and nitrite in healthy and preeclampsia pregnancies. (2013) (25)
- A plateau detected in lead accumulation in subsurface deciduous enamel from individuals exposed to lead may be useful to identify children and regions exposed to higher levels of lead. (2008) (25)
- Antihypertensive effects exerted by enalapril in mild to moderate hypertension are not associated with changes in the circulating levels of nitric oxide-related markers (2011) (24)
- Pharmacogenomics And Hypertension: Current Insights (2019) (24)
- eNOS polymorphism associated with metabolic syndrome in children and adolescents (2012) (24)
- Antioxidant and antihypertensive responses to oral nitrite involves activation of the Nrf2 pathway. (2019) (24)
- Nitrate decreases xanthine oxidoreductase-mediated nitrite reductase activity and attenuates vascular and blood pressure responses to nitrite (2017) (24)
- Hypertension plus diabetes mimics the cardiomyopathy induced by nitric oxide inhibition in rats. (2002) (23)
- A critical review of biomarkers used for monitoring human exposure to lead: advantages, limitations and future needs (2006) (23)
- Severity dependent increases in circulating cardiac troponin I and MMP-9 concentrations after experimental acute pulmonary thromboembolism. (2008) (23)
- Silicate increases the release of MMP-9 forms in peripheral blood: why gelatin zymography differs significantly in citrate plasma and serum obtained with or without clot activators. (2007) (23)
- A common matrix metalloproteinase (MMP)-2 polymorphism affects plasma MMP-2 levels in subjects environmentally exposed to mercury. (2011) (23)
- Vitamin D receptor polymorphisms in hypertensive disorders of pregnancy (2012) (23)
- Gene–Gene Interactions Among PRKCA, NOS3 and BDKRB2 Polymorphisms Affect the Antihypertensive Effects of Enalapril (2017) (23)
- Sildenafil improves the beneficial hemodynamic effects exerted by atorvastatin during acute pulmonary thromboembolism. (2011) (23)
- Pharmacogenetics of erectile dysfunction: navigating into uncharted waters. (2014) (23)
- [Role of nitric oxide in the control of the pulmonary circulation: physiological, pathophysiological, and therapeutic implications]. (2008) (23)
- Vascular endothelial growth factor (VEGF) and endothelial nitric oxide synthase (NOS3) polymorphisms are associated with high relapse risk in childhood acute lymphoblastic leukemia (ALL). (2010) (22)
- Functional MMP-9 polymorphisms modulate plasma MMP-9 levels in multiple sclerosis patients (2012) (22)
- Endothelial nitric oxide synthase haplotypes associated with hypertension do not predispose to cardiac hypertrophy. (2010) (22)
- Ethnicity affects the distribution of δ-aminolevulinic acid dehydratase (ALAD) genetic variants (2006) (22)
- Matrix metalloproteinase (MMP)-2 decreases calponin-1 levels and contributes to arterial remodeling in early hypertension. (2016) (22)
- The antihypertensive effects of sodium nitrite are not associated with circulating angiotensin converting enzyme inhibition. (2014) (22)
- Is There a Place for Inhaled Nitric Oxide in the Therapy of Acute Pulmonary Embolism? (2002) (21)
- Nitrite exerts antioxidant effects, inhibits the mTOR pathway and reverses hypertension‐induced cardiac hypertrophy (2018) (21)
- Matrix metalloproteinase-2-induced epidermal growth factor receptor transactivation impairs redox balance in vascular smooth muscle cells and facilitates vascular contraction (2018) (21)
- Relationship between Arginase 1 and Arginase 2 levels and genetic polymorphisms with erectile dysfunction. (2015) (21)
- Genetic variants in matrix metalloproteinase-9 gene modify metalloproteinase-9 levels in black subjects. (2012) (21)
- Matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in congestive heart failure. (2006) (21)
- Assessment of vascular effects of tamoxifen and its metabolites on the rat perfused hindquarter vascular bed. (2009) (20)
- Imbalanced matrix metalloproteinases in cardiovascular complications of end-stage kidney disease: a potential pharmacological target. (2012) (20)
- Haptoglobin polymorphism affects nitric oxide bioavailability in preeclampsia (2013) (20)
- The relationship between training status, blood pressure and uric acid in adults and elderly (2013) (20)
- Maternal iNOS genetic polymorphisms and hypertensive disorders of pregnancy (2012) (20)
- Correlations among antiangiogenic factors and trace elements in hypertensive disorders of pregnancy. (2015) (20)
- Comprehensive Evaluation of the Effects of Enalapril on Matrix Metalloproteinases Levels in Hypertension (2012) (20)
- Effects of Matrix Metalloproteinase (MMP)‐2 Polymorphisms on Responsiveness to Antihypertensive Therapy of Women with Hypertensive Disorders of Pregnancy (2012) (19)
- Tempol improves xanthine oxidoreductase-mediated vascular responses to nitrite in experimental renovascular hypertension (2016) (19)
- Nitrite treatment downregulates vascular MMP‐2 activity and inhibits vascular remodeling in hypertension independently of its antihypertensive effects (2019) (19)
- Plasma levels of increased miR-195-5p correlates with the sFLT-1 levels in preeclampsia (2016) (19)
- Effects of NAMPT polymorphisms and haplotypes on circulating visfatin/NAMPT levels in hypertensive disorders of pregnancy (2015) (19)
- Mercury exposure increases circulating net matrix metalloproteinase (MMP)-2 and MMP-9 activities. (2009) (19)
- VEGF genetic polymorphisms affect the responsiveness to sildenafil in clinical and postoperative erectile dysfunction (2012) (19)
- Matrix Metalloproteinase (MMP)-2 Genetic Variants Modify the Circulating MMP-2 Levels in End-Stage Kidney Disease (2012) (19)
- Ethanol consumption increases the expression of endothelial nitric oxide synthase, inducible nitric oxide synthase and metalloproteinases in the rat kidney (2012) (19)
- Gene–gene interactions in the NAMPT pathway, plasma visfatin/NAMPT levels, and antihypertensive therapy responsiveness in hypertensive disorders of pregnancy (2016) (18)
- Correlations between circulating levels of adipokines and anti-angiogenic factors in women with BMI <30 and a late-onset preeclampsia (2014) (18)
- eNOS tag SNP haplotypes in hypertensive disorders of pregnancy. (2012) (18)
- Should we measure serum or plasma lead concentrations? (2010) (18)
- Myeloperoxidase in Hypertensive Disorders of Pregnancy and Its Relation With Nitric Oxide (2017) (18)
- Pharmacogenetic implications of the eNOS polymorphisms for cardiovascular action drugs. (2011) (18)
- Doxycycline Prevents Acute Pulmonary Embolism-Induced Mortality and Right Ventricular Deformation in Rats (2013) (18)
- Low nitric oxide bioavailability is associated with better responses to sildenafil in patients with erectile dysfunction (2013) (18)
- Preeclamptic plasma stimulates the expression of miRNAs, leading to a decrease in endothelin-1 production in endothelial cells. (2018) (18)
- Endothelial nitric oxide synthase tagSNPs influence the effects of enalapril in essential hypertension. (2016) (18)
- Intron 4 polymorphism of the endothelial nitric oxide synthase (eNOS) gene is associated with decreased NO production in a mercury-exposed population. (2012) (17)
- A functional matrix metalloproteinase (MMP)-9 polymorphism modifies plasma MMP-9 levels in subjects environmentally exposed to mercury. (2010) (17)
- Chronic ethanol consumption induces histopathological changes and increases nitric oxide generation in the rat liver. (2011) (17)
- Specific matrix metalloproteinase 9 (MMP-9) haplotype affect the circulating MMP-9 levels in women with migraine (2012) (17)
- Antioxidant treatment protects against matrix metalloproteinase activation and cardiomyocyte injury during acute pulmonary thromboembolism (2012) (17)
- Ethanol consumption increases endothelin-1 expression and reactivity in the rat cavernosal smooth muscle. (2013) (17)
- Effect of genetic polymorphisms of vascular endothelial growth factor on left ventricular hypertrophy in patients with systemic hypertension. (2014) (17)
- Plasma matrix metalloproteinase-9 levels, MMP-9 gene haplotypes, and cardiovascular risk in obese subjects (2016) (17)
- Simvastatin treatment increases nitrite levels in obese women: modulation by T(-786)C polymorphism of eNOS. (2013) (17)
- Pravastatin reduces myocardial lesions induced by acute inhibition of nitric oxide biosynthesis in normocholesterolemic rats. (2001) (16)
- The effects of NAMPT haplotypes and metabolic risk factors on circulating visfatin/NAMPT levels in childhood obesity (2013) (16)
- Elevated Plasma Hemoglobin Levels Increase Nitric Oxide Consumption in Experimental and Clinical Acute Pulmonary Thromboembolism* (2013) (16)
- Preanalytical pitfalls of blood sampling to measure true circulating matrix metalloproteinase 9 and tissue inhibitors of matrix metalloproteinases. (2006) (15)
- Effects of endothelial nitric oxide synthase tagSNPs haplotypes on nitrite levels in black subjects. (2013) (15)
- Endothelial nitric oxide synthase polymorphism rs3918226 associated with hypertension does not affect plasma nitrite levels in healthy subjects. (2012) (15)
- Vitamin D receptor haplotypes affect lead levels during pregnancy. (2010) (15)
- Alterations in cyclic GMP levels in preeclampsia may reflect increased B-type natriuretic peptide levels and not impaired nitric oxide activity. (2011) (15)
- Increased activity of MMP‐2 in hypertensive obese children is associated with hypoadiponectinemia (2015) (15)
- Nitrite-stimulated Gastric Formation of S-nitrosothiols As An Antihypertensive Therapeutic Strategy. (2019) (15)
- Lack of association between genetic polymorphism of FTO, AKT1 and AKTIP in childhood overweight and obesity. (2016) (15)
- The effects of endothelial nitric oxide synthase tagSNPs on nitrite levels and risk of hypertension and obesity in children and adolescents (2014) (15)
- Functional polymorphism located in MMP-9 gene promoter is strongly associated with obesity. (2012) (15)
- Sodium nitrite attenuates MMP-9 production by endothelial cells and may explain similar effects of atorvastatin (2016) (15)
- Endothelial nitric oxide synthase polymorphisms affect the changes in blood pressure and nitric oxide bioavailability induced by propofol. (2018) (15)
- Polymorphisms of the adiponectin gene in gestational hypertension and pre-eclampsia (2014) (14)
- Evaluation of the in vivo thrombolytic activity of a metalloprotease from Bothrops atrox venom using a model of venous thrombosis. (2016) (14)
- Plasma cGMP levels in air embolism-induced acute lung injury. (2000) (14)
- Inducible Nitric Oxide Synthase Polymorphisms and Nitric Oxide Levels in Individuals with Chronic Periodontitis (2017) (14)
- T allele of −344C/T polymorphism in aldosterone synthase gene is not associated with resistant hypertension (2009) (14)
- Functional VEGF haplotypes affect the susceptibility to hypertension (2013) (14)
- Sodium nitrite improves hypertension-induced myocardial dysfunction by mechanisms involving cardiac S-nitrosylation. (2019) (14)
- Perivascular adipose tissue contributes to lethal sepsis-induced vasoplegia in rats. (2019) (14)
- Matrix metalloproteinase inhibition attenuates right ventricular dysfunction and improves responses to dobutamine during acute pulmonary thromboembolism (2013) (13)
- Matrix Metalloproteinases on Severe COVID-19 Lung Disease Pathogenesis: Cooperative Actions of MMP-8/MMP-2 Axis on Immune Response through HLA-G Shedding and Oxidative Stress (2022) (13)
- Endogenous nitric oxide formation correlates negatively with circulating matrix metalloproteinase (MMP)-2 and MMP-9 levels in black subjects (2011) (13)
- Vascular endothelial growth factor haplotypes associated with childhood obesity. (2011) (13)
- Ethnicity affects the distribution of delta-aminolevulinic acid dehydratase (ALAD) genetic variants. (2006) (13)
- Matrix metalloproteinases as drug targets in acute pulmonary embolism. (2013) (13)
- Effect of Multicomponent Training on Blood Pressure, Nitric Oxide, Redox Status, and Physical Fitness in Older Adult Women: Influence of Endothelial Nitric Oxide Synthase (NOS3) Haplotypes (2017) (13)
- Acute cardiac and hemodynamic effects of sildenafil on resistant hypertension (2013) (13)
- Role of adiponectin on antioxidant profile: evaluation during healthy and hypertensive disorders of pregnancy (2016) (12)
- nNOS polymorphisms are associated with responsiveness to sildenafil in clinical and postoperative erectile dysfunction. (2014) (12)
- Plasma levels of matrix metalloproteinase-9 are elevated in individuals with hypertensive crisis (2020) (12)
- Angiotensin converting enzyme inhibitors enhance the hypotensive effects of propofol by increasing nitric oxide production (2018) (12)
- Functional matrix metalloproteinase (MMP)-9 genetic variants modify the effects of hemodialysis on circulating MMP-9 levels. (2012) (12)
- Assessment of how pregnancy modifies plasma lead and plasma/whole blood lead ratio in ALAD 1-1 genotype women. (2008) (12)
- Captopril and Lisinopril Only Inhibit Matrix Metalloproteinase‐2 (MMP‐2) Activity at Millimolar Concentrations (2014) (12)
- Functional characterization of the 5′‐regulatory region of human CYP2C19 (2003) (12)
- Chronic treatment with quercetin does not inhibit angiotensin-converting enzyme in vivo or in vitro. (2010) (12)
- Chronic ethanol consumption reduces adrenomedullin-induced relaxation in the isolated rat aorta. (2011) (12)
- Matrix Metalloproteinase‐2 Activity is Associated with Divergent Regulation of Calponin‐1 in Conductance and Resistance Arteries in Hypertension‐induced Early Vascular Dysfunction and Remodelling (2017) (11)
- Increases in circulating matrix metalloproteinase-9 levels following fibrinolysis for acute pulmonary embolism. (2010) (11)
- Sequence diversity and functional characterization of the 5'-regulatory region of human CYP2C19. (2003) (11)
- Ethanol consumption alters the expression and reactivity of adrenomedullin in the rat mesenteric arterial bed. (2012) (11)
- Reduction of blood nitric oxide levels is associated with clinical improvement of the chronic pelvic pain related to endometriosis (2015) (11)
- Influence of arginase polymorphisms and arginase levels/activity on the response to erectile dysfunction therapy with sildenafil (2017) (11)
- Adiponectin ‐11377C/G and +276G/T Polymorphisms affect Adiponectin Levels but do not Modify Responsiveness to Therapy in Resistant Hypertension (2015) (10)
- Aldosterone synthase gene polymorphism is not associated with gestational hypertension or preeclampsia. (2009) (10)
- Endothelial nitric oxide synthase polymorphisms and susceptibility to hypertension: genotype versus haplotype analysis. (2007) (10)
- Endothelial nitric oxide genotypes and haplotypes are not associated with end-stage renal disease. (2011) (10)
- Association of Mineralocorticoid Receptor Polymorphism I180V With Left Ventricular Hypertrophy in Resistant Hypertension. (2016) (10)
- Contrasting effects of low versus high ascorbate doses on blood pressure responses to oral nitrite in L-NAME-induced hypertension. (2018) (10)
- Pharmacogenetic relevance of endothelial nitric oxide synthase polymorphisms and gene interactions. (2018) (10)
- Hemodynamic effects of bupropion in anesthetized dogs. (2006) (9)
- Circulating matrix metalloproteinases and their endogenous inhibitors in patients with erectile dysfunction (2012) (9)
- The role of heart rate in the modulation of the decreased cardiac output induced by acute nitric oxide synthesis inhibition in anaesthetized dogs. (1999) (9)
- Adiponectin associates positively with nitrite levels in children and adolescents (2013) (9)
- Direct renin inhibition is not enough to prevent reactive oxygen species generation and vascular dysfunction in renovascular hypertension (2018) (9)
- Training Status as a Marker of the Relationship between Nitric Oxide, Oxidative Stress, and Blood Pressure in Older Adult Women (2015) (9)
- Influence of training status and eNOS haplotypes on plasma nitrite concentrations in normotensive older adults: a hypothesis-generating study (2014) (9)
- TNF-α inhibition decreases MMP-2 activity, reactive oxygen species formation and improves hypertensive vascular hypertrophy independent of its effects on blood pressure. (2020) (9)
- Haplotype analysis can provide improved clinical information than single genotype analysis. (2007) (8)
- Nitric oxide inhalation during massive pulmonary embolism. (1999) (8)
- Maternal Flow-Mediated Dilation and Nitrite Concentration During Third Trimester of Pregnancy and Postpartum Period (2013) (8)
- LOW-DOSE INHALED NITRIC OXIDE (NO) ATTENUATES HEMODYNAMIC CHANGES FOLLOWING ACUTE PULMONARY AIR EMBOLISM (PAE) IN DOGS (1998) (8)
- Endothelin-1 attenuates bradykinin-induced hypotension in rats. (2000) (8)
- Circulating Total Cell-Free DNA Levels Are Increased in Hypertensive Disorders of Pregnancy and Associated with Prohypertensive Factors and Adverse Clinical Outcomes (2021) (8)
- Homocysteine and nitrite levels are modulated by MTHFR 677C>T polymorphism in obese women treated with simvastatin (2014) (8)
- C-Type Natriuretic Peptide Induces Anti-contractile Effect Dependent on Nitric Oxide, Oxidative Stress, and NPR-B Activation in Sepsis (2016) (8)
- Verapamil decreases calpain-1 and matrix metalloproteinase-2 activities and improves hypertension-induced hypertrophic cardiac remodeling in rats. (2019) (8)
- Activation of the TRKB receptor mediates the panicolytic-like effect of the NOS inhibitor aminoguanidine (2019) (8)
- Genetic Effects of eNOS Polymorphisms on Biomarkers Related to Cardiovascular Status in a Population Coexposed to Methylmercury and Lead (2015) (8)
- Tamoxifen and Its Metabolites Cause Acute Vasorelaxation of Aortic Rings by Inducing Vasodilator Prostanoid Synthesis (2011) (8)
- Chronic ethanol consumption increases reactive oxygen species generation and the synthesis of pro-inflammatory proteins in the heart through TNFR1-dependent mechanisms. (2019) (8)
- Review Article Role of nitric oxide in the control of the pulmonary circulation: physiological, pathophysiological, and therapeutic implications* Papel do óxido nítrico na regulação da circulação pulmonar: implicações fisiológicas, fisiopatológicas e terapêuticas (2008) (8)
- Antihypertensive therapy in pre-eclampsia: effects of plasma from nonresponsive patients on endothelial gene expression. (2016) (8)
- MDR-1 C3435T polymorphism may affect blood pressure in resistant hypertensive patients independently of its effects on aldosterone release (2014) (8)
- Serum or Plasma Matrix Metalloproteinase (MMP)-9 Levels and Cardiovascular Diseases (2018) (8)
- Perivascular adipose tissue protects against the vascular dysfunction induced by acute ethanol intake: Role of hydrogen peroxide. (2018) (8)
- Imbalanced matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 activities in patients with thromboangiitis obliterans (2012) (7)
- Consistent gastric pH-dependent effects of suppressors of gastric acid secretion on the antihypertensive responses to oral nitrite. (2020) (7)
- Letter by Pinheiro et al regarding article, "unexpected effect of proton pump inhibitors: elevation of the cardiovascular risk factor asymmetric dimethylarginine". (2014) (7)
- Oral nitrite treatment increases S-nitrosylation of vascular protein kinase C and attenuates the responses to angiotensin II (2020) (7)
- The antioxidant tempol decreases acute pulmonary thromboembolism-induced hemolysis and nitric oxide consumption. (2013) (7)
- Inhaled nitric oxide and amniotic fluid embolism. (1999) (7)
- Oral Contraceptive Containing Chlormadinone Acetate and Ethinylestradiol Reduces Plasma Concentrations of Matrix Metalloproteinase‐2 in Women with Polycystic Ovary Syndrome (2012) (7)
- Relationship between asymmetric dimethylarginine, nitrite and genetic polymorphisms: Impact on erectile dysfunction therapy. (2017) (7)
- Hemodynamic effects of a combination of bupropion and nicotine in anesthetized dogs (2007) (6)
- Circulating Matrix Metalloproteinase-9 Levels as a Biomarker of Disease (2005) (6)
- Acute administration of nicotine impairs the hypotensive responses to bradykinin in rats. (2001) (6)
- Treatment with nitrite prevents reactive oxygen species generation in the corpora cavernosa and restores intracavernosal pressure in hypertensive rats. (2019) (6)
- Nitric oxide in the dorsal periaqueductal gray mediates the panic-like escape response evoked by exposure to hypoxia (2019) (6)
- Recombinant Human Matrix Metalloproteinase‐2 Impairs Cardiovascular β‐Adrenergic Responses (2013) (6)
- Aminoguanidine produces beneficial haemodynamic effects in a canine model of acute pulmonary thromboembolism (2007) (6)
- Nitrate and nitrite‐based therapy to attenuate cardiovascular remodelling in arterial hypertension (2020) (6)
- Arginase II polymorphisms modify the hypotensive responses to propofol by affecting nitric oxide bioavailability (2021) (5)
- Antihypertensive therapy in preeclampsia is not modulated by VEGF polymorphisms (2015) (5)
- DDAH1 and DDAH2 polymorphisms associate with asymmetrical dimethylarginine plasma levels in erectile dysfunction patients but not in healthy controls. (2019) (5)
- Association of endothelial nitric oxide synthase (eNOS) gene polymorphisms and physical fitness levels with plasma nitrite concentrations and arterial blood pressure values in older adults (2018) (5)
- Losartan exerts no protective effects against acute pulmonary embolism-induced hemodynamic changes (2012) (5)
- Mechanisms underlying vascular hypocontractility induced by ethanol withdrawal: Role of cyclooxygenase 2‐derived prostacyclin (2019) (5)
- Circulating matrix metalloproteinase-9 levels as a possible marker of aortic stiffness. (2005) (4)
- The effects of endothelial nitric oxide synthase tagSNPs on nitrite levels and risk of hypertension and obesity in children and adolescents (2015) (4)
- Activation of nitric oxide‐cyclic GMP pathway (NO‐cGMP) with nitrite or sildenafil, but not BAY 41‐2272 (BAY), blunts acute pulmonary embolism (APE)‐induced increases in circulating matrix metalloproteinase‐9 (MMP‐9) and oxidative stress (2009) (4)
- Dysregulated mitogen-activated protein kinase and matrix metalloproteinase in ethanol-induced cavernosal dysfunction. (2018) (4)
- Abstract 301: Nebivolol Attenuates Prooxidant and Profibrotic Mechanisms and Decreases Vascular Remodeling in Renovascular Hypertension (2013) (4)
- Targeting Matrix Metalloproteinases in Disease Conditions (2014) (4)
- A comprehensive time course study of tissue nitric oxide metabolites concentrations after oral nitrite administration. (2020) (4)
- Association between endothelial nitric oxide synthase and the renin-angiotensin-aldosterone system polymorphisms, blood pressure and training status in normotensive/pre-hypertension and hypertensive older adults: a pilot study (2021) (4)
- Omeprazole induces vascular remodeling by mechanisms involving xanthine oxidoreductase and matrix metalloproteinase activation. (2021) (4)
- NAMPT single-nucleotide polymorphism rs1319501 and visfatin/NAMPT affect nitric oxide formation, sFlt-1 and antihypertensive therapy response in preeclampsia. (2021) (4)
- Chemical modification of high density lipoprotein subfractions - HDL2 and HDL3 - after use of atorvastatin. (2014) (4)
- Nitric oxide attenuates matrix metalloproteinase-9 production by endothelial cells independent of cGMP- or NFκB-mediated mechanisms (2013) (4)
- Antioxidant effects of phosphodiesterase-5 inhibitors. (2013) (3)
- Artigo OriginalLack of association between genetic polymorphism of FTO, AKT1 and AKTIP in childhood overweight and obesityFalta de associação entre o polimorfismo genético do FTO, AKT1 e AKTIP e o sobrepeso e a obesidade infantis☆ (2016) (3)
- Impaired xanthine oxidoreductase (XOR)-mediated nitrite reductase activity possibly involved in the lack of antihypertensive effects of XOR inhibitors (2017) (3)
- Inhaled nitric oxide and pulmonary embolism (1998) (3)
- Association of 11β-hydroxysteroid dehydrogenase type1 (HSD11b1) gene polymorphisms with outcome of antidepressant therapy and suicide attempts (2019) (3)
- Capnography and the diagnosis of gas embolism. (1999) (3)
- Misuse of serum matrix metalloproteinase (MMP)-9 and tissue inhibitor of metalloproteinase (TIMP)-1 as a biomarker in multiple sclerosis. (2006) (3)
- Comment on ‘Cardiac effects of 6 months' dietary nitrate and spironolactone in patients with hypertension and with/at risk of type 2 diabetes, in the factorial design, double‐blind, randomised controlled VaSera trial’ by Faconti et al. (2019) (2)
- Longitudinal assessment of maternal-fetal Doppler parameters and maternal plasma level of matrix metalloproteinases 2 and 9 (2016) (2)
- NAMPT levels are inversely related to nitric oxide formation and positively related to soluble fms-like tyrosine kinase-1 levels in preeclampsia. (2019) (2)
- EFFECTS OF UNDER NUTRITION DURING SUCKLING ON THE BEHAVIOURAL RESPONSES OFWEANLING RATS TO SCH23390 (1997) (2)
- Proton pump inhibitors: New mechanisms of action (2019) (2)
- Is there a place for inhaled nitric oxide in the therapy of massive pulmonary embolism? (2001) (2)
- On the origin of nitrosylated hemoglobin in COVID-19: Endothelial NO capture or redox conversion of nitrite? (2022) (2)
- Circulating HO-1 levels are not associated with plasma sFLT-1 and GTn HMOX1 polymorphism in preeclampsia (2019) (2)
- Papel do óxido nítrico na regulação da circulação pulmonar: implicações fisiológicas, fisiopatológicas e terapêuticas* Role of nitric oxide in the control of the pulmonary circulation: physiological, pathophysiological, and therapeutic implications (2008) (2)
- A new mixed model of periodontitis-induced preeclampsia: A pilot study. (2021) (2)
- Soluble Fms-Like Tyrosine Kinase-1 and Soluble Endogline in Preeclampsia Nitric Oxide Formation Is Inversely Related to Serum Levels of Antiangiogenic Factors (2008) (2)
- INHALED NITRIC OXIDE (NO) IMPROVES HEMODYNAMICS DURING A VENOUS AIR INFUSION (VAI) IN DOGS (1998) (2)
- Antiseptic mouthwash inhibits antihypertensive and vascular protective effects of L-arginine. (2021) (2)
- Serum samples should not be used to assess circulating matrix metalloproteinase‐9 levels as a prognostic marker of disease (2006) (2)
- PULMONARY EMBOLISM AND IMPENDING PARADOXICAL EMBOLISM : A ROLE FOR TRANSESOPHAGEAL ECHOCARDIOGRAPHY? AUTHORS' REPLY (1999) (1)
- Matrix Metalloproteinases: A Target in In-Stent Restenosis? (2013) (1)
- Pulmonary embolism and impending paradoxical embolism: A role for transesophageal echocardiography? (1999) (1)
- Matrix metalloproteinase 2 increases ROS in aortic tissue (1153.10) (2014) (1)
- In reply to: Enalapril and the VEGFA gene: personalized medicine in hypertension therapy (2015) (1)
- Targeting RV failure and cardiomyocyte injury in acute pulmonary thromboembolism (2013) (1)
- Chronic ethanol consumption induces micturition dysfunction and alters the oxidative state of the urinary bladder. (2019) (1)
- Assessment of nitrite oxide and maternal–fetal Doppler parameters during pregnancy (2016) (1)
- Treatment of massive pulmonary embolism. (2001) (1)
- Gene–gene interactions in the protein kinase C/endothelial nitric oxide synthase axis impact the hypotensive effects of propofol (2021) (1)
- Avoid fentanyl-induced "wooden chest syndrome" in the emergency department. (2018) (1)
- Gastroesophageal Reflux Treatment With Proton Pump Inhibitors in Patients With Hypertension. (2018) (1)
- Matrix metalloproteinase (MMP)‐9 and VEGF gene interaction models and MMP‐9 plasma levels in preeclampsia and gestational hypertension (2012) (1)
- P46: Low sodium nitrite (but not nitrate) concentrations attenuate MMP-9 production by endothelial cells (2013) (1)
- The use of inhaled nitric oxide during gas embolism. (1999) (1)
- Combining drugs to optimize the therapy of hypertension: experimental evidence derived from animal models (2015) (1)
- Nitrite and tempol combination promotes synergic effects and alleviates right ventricular wall stress during acute pulmonary thromboembolism. (2021) (1)
- Inhaled nitric oxide as a coadjuvant therapy after massive pulmonary embolism (1999) (1)
- Antioxidant effect of doxycycline decreases MMP activity and blood pressure in SHR (2013) (1)
- P188 - Plasma arginase activity may affect the responses to sildenafil in patients with erectile dysfunction (2014) (1)
- P43. Enhanced concentrations of markers of nitric oxide formation after exercise training in patients with metabolic syndrome (2008) (1)
- 41 Circulating level of TIMP-4 is elevated in preeclampsia (2016) (1)
- Editorial (Hot Topic: Matrix Metalloproteinases: Drug Targets in Cardiovascular Diseases) (2013) (0)
- Small-dose inhaled nitric oxide and pulmonary embolism. (2000) (0)
- Orally administered sodium nitrite prevents the increased α-1 adrenergic vasoconstriction induced by hypertension and promotes the S-nitrosylation of calcium/calmodulin-dependent protein kinase II. (2023) (0)
- Nitrite and Nitrosoglutathione Treatments Prevent Hypertensive Effects of Angiotensin II by Mechanisms Involving Nitrosylation (2016) (0)
- Antioxidant tempol modulates the increases in tissue nitric oxide metabolites concentrations after oral nitrite administration. (2021) (0)
- Haplotypes but not genotypes are associated with hypertension (2005) (0)
- Inducible nitric oxide synthase haplotype associated with migraine and aura (2012) (0)
- Antioxidant treatment protects against matrix metalloproteinase activation and cardiomyocyte injury during acute pulmonary thromboembolism (2012) (0)
- PSS228 – Mouthwash Blunts Chronic Antihypertensive Effects of Sodium Nitrate in Renovascular Hypertensive Rats (2013) (0)
- eNOS polymorphism associated with metabolic syndrome in children and adolescents (2012) (0)
- Sodium Nitrate Attenuates the Acute Antihypertensive and Vascular Effects of Sodium Nitrite by Inhibiting Nitrite-Reductase Activity of Xanthine Oxidoreductse (2016) (0)
- Acute cardiac and hemodynamic effects of sildenafil on resistant hypertension (2013) (0)
- Cardiovascular mortality in high-risk patients and T-786C polymorphism in promoter region of the endothelial nitric oxide synthase gene. (2007) (0)
- Pathophysiology, Diagnosis and Treatment of Pulmonary Embolism Focusing on Thrombolysis - New approaches (2012) (0)
- Abstract 189: Omeprazole Decreases Chronic Antihypertensive Effects of Sodium Nitrite (2012) (0)
- Letter to the Editor (2006) (0)
- Antioxidants effects of doxycycline, an inhibitor of MMPS, ameliorates vascular hypertrophy in 2K1C hypertension (2011) (0)
- Antioxidant effects of phosphodiesterase-5 inhibitors : reply (2013) (0)
- PDE5 INHIBITION IMPROVES DIASTOLIC FUNCTION IN RESISTANT HYPERTENSIVE PATIENTS BY BLOOD PRESSURE INDEPENDENT MECHANISM AND ENDOTHELIAL FUNCTION: PP.21.155 (2011) (0)
- Quercetin decreases cardiac hypertrophic mediators and maladaptive coronary arterial remodeling in renovascular hypertensive rats without improving cardiac function (2022) (0)
- Abstract 459: Gene-Gene Interaction Among Endothelial Nitric Oxide Syntase (eNOS), Matrix Metalloproteinase-9 (MMP-9) and Vascular Endothelial Growth Factor (VEGF) in the Childhood Obesity (2012) (0)
- P44: Nitric oxide may modulate matrix metalloproteinase-2 during renovascular hypertension (2013) (0)
- VEGF polymorphisms modulate antihypertensive therapy in preeclampsia (2009) (0)
- High molecular weight adiponectin as a biomarker of hypertension in children and adolescents with obesity. (2023) (0)
- Vascular xanthine oxidoreductase contributes to the antihypertensive effects of sodium nitrite in l-NAME hypertension (2014) (0)
- Polymorphisms in VEGFA gene affect the antihypertensive responses to enalapril (2015) (0)
- L 025 Effects of Atorvastatin on the Metabolism of Hdl in People with Polymorphism T– 786c of the Gene of Enos-3 (2009) (0)
- pulmonary hypertension in chronically hypoxic rats Metalloproteinase inhibition by Batimastat attenuates (2006) (0)
- Lercanidipine(LER) improves the endothelial dysfunction in diabetic rats (2005) (0)
- Low nitric oxide bioavailability predicts better responses to sildenafil in patients with erectile dysfunction (2012) (0)
- Targeting cardiomyocyte injury in acute pulmonary thromboembolism (2012) (0)
- O conhecimento em farmacogenômica pode auxiliar no controle da pressão arterial em pacientes com hipertensão de difícil controle? Is pharmacogenomic knowledge of help in the management of difficult-to-control hypertension? (2008) (0)
- 102 - Effect of Chronic Ethanol Consumption on the Increased Oxidative Stress in Rat Corpus Cavernosum Tissue (2014) (0)
- Atorvastatin and sildenafil improve endothelial dysfunction, inhibit pro-fibrotic factors, and increase nitrite concentrations in hypertension (2014) (0)
- Effect of enalapril on circulating NO and oxidative stress markers in hypertensive patients (2011) (0)
- Losartan exerts no protective effects against acute pulmonary embolism-induced hemodynamic changes (2011) (0)
- P167 - Xanthine oxidoreductase contributes to vasodilation and antihypertensive effects of sodium nitrite in renovascular hypertension (2014) (0)
- Assessment of nitric oxide metabolites concentrations in plasma, saliva, and breast milk and their relationship in lactating women (2020) (0)
- Mechanisms contributing to increased cardiovascular risk in patients taking proton pump inhibitors (2017) (0)
- Mechanisms involved in cardiovascular protection associated with a vegetarian diet. (2016) (0)
- Antihypertensive and antioxidant effects of a single daily dose of sodium nitrite in a model of renovascular hypertension (2012) (0)
- Increased Proton Pump Inhibitors−Induced Mortality Risk in Hemodialysis Patients (2018) (0)
- Circulating matrix metalloproteinases levels and their inhibitors in clinical and experimental hypertension (2011) (0)
- Sodium nitrite attenuates MMP-9 production by endothelial cells and may explain similar effects of atorvastatin (2015) (0)
- END-TIDAL CO2 AFTER CO2 EMBOLISM. AUTHORS' REPLY (1998) (0)
- Ranitidine treatment impairs vascular redox biology and function (2018) (0)
- Sildena fi l improves the bene fi cial hemodynamic effects exerted by atorvastatin during acute pulmonary thromboembolism (2011) (0)
- 162 - Nitrite Modulates Mitochondrial Function Through PKA Activation and AKAP121 Expression Under Normoxia (2015) (0)
- Pentoxifylline treatment decreases MMP-2 activity, oxidative stress and vascular hypertrophy in renovascular hypertension (2018) (0)
- PP.13.23: EFFECT OF CHRONIC ETHANOL CONSUMPTION ON THE ERECTILE FUNCTION AND BLOOD PRESSURE OF RATS ROLE OF OXIDATIVE STRESS (2015) (0)
- Effects of atorvastatin on plasma MMP-2 and MMP-9 activity in healthy volunteers (2006) (0)
- Nicotine accutely increases plasma MMP-9 activity (2005) (0)
- Low nitric oxide bioavailability is associated with better responses to sildenafil in patients with erectile dysfunction (2013) (0)
- Gelatinases activity in aortas is associated with chronic lead (PB) exposure-induced hypertension (2007) (0)
- INHALED NITRIC OXIDE AND AMNIOTIC FLUID EMBOLISM. AUTHOR'S REPLY (1999) (0)
- 106 - Nitrite Activates Protein Kinase A and Increases AKinase Anchoring Protein Expression to Regulate Mitochondrial Function in Non-Hypoxic Conditions (2014) (0)
- Abstract P3022: Pentoxifylline Exerts Antiinflammatory And Antioxidant Effects, Inhibits MMP-2 Activity And Attenuates Renovascular Hypertension-Induced Vascular Alterations (2019) (0)
- Effects of probiotics in rats with experimental metabolic syndrome and periodontitis: an investigation of the intestine-adipose tissue axis. (2023) (0)
- Vitamin D receptor polymorphisms in hypertensive disorders of pregnancy (2012) (0)
- 1326 LIVER IMMUNOLOCALIZATION AND TISSUE EXPRESSION OF METALLOPREOTEINASE-9 (MMP-9) IN NONALCOHOLIC FATTY LIVER DISEASE (NAFLD) (2012) (0)
- Temporal evaluation of 2K1C model of renovascular hypertension: metalloproteinases and oxidative stress (2010) (0)
- Genetic factors modulate lead concentrations in the organism (2009) (0)
- Plasma matrix metalloproteinase-9 levels, MMP-9 gene haplotypes, and cardiovascular risk in obese subjects (2016) (0)
- Effect of metabolic syndrome risk factors and MMP-2 genetic variations on circulating MMP-2 levels in childhood obesity (2012) (0)
- Matrix Metalloproteinase (MMP)‐2 Diverges in Regulate Calponin‐1 in Conductance and Resistance Arteries in Early Hypertension‐Induced Vascular Dysfunction and Remodeling (2017) (0)
- The rs2682826 Polymorphism of the NOS1 Gene Is Associated with the Degree of Disability of Erectile Dysfunction (2023) (0)
- Matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in multiple sclerosis (2006) (0)
- P-112: Myocardial and vascular remodeling and biochemical markers of vascular dysfunction in refractory hypertensives (2001) (0)
- PSS229 - Nitrite Increases Mitochondrial Function in Normoxia through the Activation of Protein Kinase a and Phosphorylation of Cytochrome C Oxidase (2013) (0)
- The Association of Biochemical and Genetic Biomarkers in VEGF Pathway with Depression (2022) (0)
- TRPA1 Polymorphisms Modify the Hypotensive Responses to Propofol with No Change in Nitrite or Nitrate Levels (2022) (0)
- Doxycycline treatment exerts antioxidant effects and decreases angiotensin-converting enzyme activity in renovascular hypertension (2018) (0)
- Nitrite Inhibits Mitochondrial Phosphodiesterase and Activates CAMP-PKA-AKAP1 Signaling to Modulate Mitochondrial Function and Cytoprotection in Normoxia (2016) (0)
- Whole blood and plasma nitrite levels are influenced by eNOS polymorphism in healthy and hypertensive pregnant women (2009) (0)
- PP.20.30: ASSOCIATION BETWEEN VASCULAR STIFFNESS AND MATRIX METALLOPROTEINASE 9 IN HYPERTENSIVE INDIVIDUALS (2015) (0)
- Letter by de Paula et al Regarding Article, "Improvement in Outcomes After Cardiac Arrest and Resuscitation by Inhibition of S-Nitrosoglutathione Reductase". (2019) (0)
- Abstract 265: Chronic Treatment with Nebivolol Attenuates the Vascular Changes in the 2-Kidney, 1-Clip Model of Renovascular Hypertension (2012) (0)
- Nitrite enhances mitochondrial respiration through protein kinase A activation in normoxia (2014) (0)
- Antiarrhythmic Effects of Propofol in Children (1998) (0)
- Treatment of local anesthetic toxicity. (1999) (0)
- Imbalance between matrix metalloproteinase (MMP)‐2 and calponin‐1 in early hypertensive vascular remodeling (2015) (0)
- eNOS haplotype associated with hypertension in obese children and adolescents (2011) (0)
- Editorial: matrix metalloproteinases: drug targets in cardiovascular diseases. (2013) (0)
- Abstract P108: Circulating Matrix Metalloproteinase-2 Invades the Heart and Causes Heart Failure (2016) (0)
- P169 - Sodium nitrite does not inhibit circulating angiotensin converting enzyme activity (2014) (0)
- Mechanisms involved in proton pump inhibitors-induced increases in ischemic events. (2019) (0)
- P2 Effect of eNOS polymorphisms on nitrite levels in healthy and preeclamptic pregnancies (2010) (0)
- P43. Tempol enhances the nitrite-derived nitric oxide formation in vitro and in vivo (2011) (0)
- Interaction among nitric oxide (NO)-related genes in migraine susceptibility (2012) (0)
- Preliminary study about the relationship between estimated training status and RAS polymorphisms on blood pressure and ACE activity in the elderly (2018) (0)
- P33 Inter-ethnic difference of ADMA levels in healthy pregnancy and preeclampsia (2010) (0)
- P22. Endothelial nitric oxide synthase (eNOS) tagSNPs effects on the circulating nitrite in healthy black subjects (2011) (0)
- PGPM_A_230201 341..359 (2019) (0)
- Abstract 645: Atorvastatin and Sildenafil Reduce Oxidative Stress, MMP-2 And MMP-9 Levels, TGF-beta Expression and Prevent Vascular Remodeling in 2K1C-hypertension (2013) (0)
- Abstract 393: Chronic Nebivolol Treatment Attenuates MMP Activity and Oxidative Stress and Improves Renovascular Hypertension-induced Cardiac Hypertrophy (2013) (0)
- Nitric oxide attenuates matrix metalloproteinase-9 production by endothelial cells independent of cGMP- or NFκB-mediated mechanisms (2013) (0)
- Abstract 529: Atorvastatin and Sildenafil Reduce Vascular Remodeling and Oxidative Stress in 2K1C-hypertension (2012) (0)
- Chronic Treatment with Nitrite Produces Antihypertensive Effects in Renovascular Hypertension (2010) (0)
- P3. Sodium nitrite decreases vascular NADPH oxidase activity and exerts antihypertensive effects in hypertension (2011) (0)
- Abstract 316: Effects of Inhibiting of Inducible Nitric Oxide Synthase in the Pathophysiology of Experimental Preeclampsia (2012) (0)
- Reply letter to: Genetic modulation of antiinflammatory effects of atorvastatin: Probably a multi-gene condition (2008) (0)
- Nitrate-rich beet juice intake on cardiovascular performance in response to exercise in postmenopausal women with arterial hypertension: study protocol for a randomized controlled trial (2023) (0)
- Gastroesophageal Reflux Treatment With Proton Pump Inhibitors in Patients With Hypertension (2018) (0)
- 596 INTERACTIONS OF T-786C POLYMORPHISM OF ENOS GENE WITH ATORVASTATIN ON PARAMETERS OF LIPID METABOLISM IN BRAZILIAN ADULTS (2011) (0)
- Abstract 511: Nitric Oxide Attenuates Matrix Metalloproteinase-9 Production by Endothelial Cells (2012) (0)
- End-tidal CO2 after CO2 embolism (1998) (0)
- 105 - Oxidative Stress Blunts the Vasodilator Effects of Sodium Nitrite Mediated by Xanthine Oxidoreductase in 2K1C Hypertension (2015) (0)
- Abstract 297: Chronic Antihypertensive Effects of Sodium Nitrite in L-name-induced Hypertension in Rats (2012) (0)
- Lercanidipine (LER) improves the endothelial dysfunction and prevents the vascular remodeling in diabetic rats (2008) (0)
- Doxycycline improves vascular dysfunction and remodeling in renovascular hypertension via regulation of matrix metalloproteinase (MMP)‐2. (2008) (0)
- Pharmacologic therapy of pulmonary vasoconstriction in acute pulmonary embolism. (2004) (0)
- Matrix metalloproteinase-2-induced EGFR transactivation and increased ROS and vascular contraction (2018) (0)
- Lead concentrations in saliva of children living in two different areas of lead-exposure (2008) (0)
- BIOCHEMICAL AND BIOMECHANICAL FACTORS IN THE ETHIOPATHOGENESIS OF VASCULAR DYSFUNCTION IN REFRACTORY HYPERTENSIVE PATIENTS.: P 060 (2004) (0)
- L-arginine and pulmonary embolism. (2006) (0)
- eNOS gene polymorphisms may modify the effects produced by cardiovascular drugs on myocardial eNOS expression and activity. (2010) (0)
- Endogenous nitric oxide formation correlates negatively with circulating matrix metalloproteinase (MMP)-2 and MMP-9 levels in black subjects (2011) (0)
- Assessment of nitric oxide metabolites concentrations in plasma, saliva, and breast milk and their relationship in lactating women (2020) (0)
- P50 Comparative assessment of levels zinc in preeclampsia and gestational hypertension (2010) (0)
- Abstract 322: Imbalance Between MMP-2 and TIMP-4 Associated With Oxidative Stress Contributes to Temporal Renovascular Hypertension-Induced Cardiac Hypertrophy (2012) (0)
- PSS305 - Tempol Facilitates Nitrite-Derived Gastric Nitric Oxide Formation and Enhances the AntihypertensiveEffects of Ora1l Nitrite (2013) (0)
- Nitrite Differently Activates cGMP versus cAMP (2017) (0)
This paper list is powered by the following services:
